BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25851836)

  • 1. Sporadic Creutzfeldt-Jakob Disease MM1+2C and MM1 are Identical in Transmission Properties.
    Kobayashi A; Matsuura Y; Iwaki T; Iwasaki Y; Yoshida M; Takahashi H; Murayama S; Takao M; Kato S; Yamada M; Mohri S; Kitamoto T
    Brain Pathol; 2016 Jan; 26(1):95-101. PubMed ID: 25851836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology?
    Kobayashi A; Parchi P; Yamada M; Brown P; Saverioni D; Matsuura Y; Takeuchi A; Mohri S; Kitamoto T
    J Virol; 2015 Apr; 89(7):3939-46. PubMed ID: 25609817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive properties of plaque-type dura mater graft-associated Creutzfeldt-Jakob disease in cell-protein misfolding cyclic amplification.
    Takeuchi A; Kobayashi A; Parchi P; Yamada M; Morita M; Uno S; Kitamoto T
    Lab Invest; 2016 May; 96(5):581-7. PubMed ID: 26878132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prions from Sporadic Creutzfeldt-Jakob Disease Patients Propagate as Strain Mixtures.
    Cassard H; Huor A; Espinosa JC; Douet JY; Lugan S; Aron N; Vilette D; Delisle MB; Marín-Moreno A; Peran P; Beringue V; Torres JM; Ironside JW; Andreoletti O
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A traceback phenomenon can reveal the origin of prion infection.
    Kobayashi A; Asano M; Mohri S; Kitamoto T
    Neuropathology; 2009 Oct; 29(5):619-24. PubMed ID: 19659941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.
    Parchi P; Cescatti M; Notari S; Schulz-Schaeffer WJ; Capellari S; Giese A; Zou WQ; Kretzschmar H; Ghetti B; Brown P
    Brain; 2010 Oct; 133(10):3030-42. PubMed ID: 20823086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creutzfeldt-Jakob disease.
    Sikorska B; Knight R; Ironside JW; Liberski PP
    Adv Exp Med Biol; 2012; 724():76-90. PubMed ID: 22411235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease.
    Gelpi E; Baiardi S; Nos C; Dellavalle S; Aldecoa I; Ruiz-Garcia R; Ispierto L; Escudero D; Casado V; Barranco E; Boltes A; Molina-Porcel L; Bargalló N; Rossi M; Mammana A; Tiple D; Vaianella L; Stoegmann E; Simonitsch-Klupp I; Kasprian G; Klotz S; Höftberger R; Budka H; Kovacs GG; Ferrer I; Capellari S; Sanchez-Valle R; Parchi P
    Acta Neuropathol Commun; 2022 Aug; 10(1):114. PubMed ID: 35978418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-occurrence of types 1 and 2 PrP(res) in sporadic Creutzfeldt-Jakob disease MM1.
    Kobayashi A; Mizukoshi K; Iwasaki Y; Miyata H; Yoshida Y; Kitamoto T
    Am J Pathol; 2011 Mar; 178(3):1309-15. PubMed ID: 21356381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.
    Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T
    Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
    Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sequence transmission of sporadic Creutzfeldt-Jakob disease creates a new prion strain.
    Kobayashi A; Asano M; Mohri S; Kitamoto T
    J Biol Chem; 2007 Oct; 282(41):30022-8. PubMed ID: 17709374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humanized knock-in mice expressing chimeric prion protein showed varied susceptibility to different human prions.
    Taguchi Y; Mohri S; Ironside JW; Muramoto T; Kitamoto T
    Am J Pathol; 2003 Dec; 163(6):2585-93. PubMed ID: 14633630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years.
    Rudge P; Jaunmuktane Z; Adlard P; Bjurstrom N; Caine D; Lowe J; Norsworthy P; Hummerich H; Druyeh R; Wadsworth JD; Brandner S; Hyare H; Mead S; Collinge J
    Brain; 2015 Nov; 138(Pt 11):3386-99. PubMed ID: 26268531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease.
    Collins SJ; Sanchez-Juan P; Masters CL; Klug GM; van Duijn C; Poleggi A; Pocchiari M; Almonti S; Cuadrado-Corrales N; de Pedro-Cuesta J; Budka H; Gelpi E; Glatzel M; Tolnay M; Hewer E; Zerr I; Heinemann U; Kretszchmar HA; Jansen GH; Olsen E; Mitrova E; Alpérovitch A; Brandel JP; Mackenzie J; Murray K; Will RG
    Brain; 2006 Sep; 129(Pt 9):2278-87. PubMed ID: 16816392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct origins of dura mater graft-associated Creutzfeldt-Jakob disease: past and future problems.
    Kobayashi A; Matsuura Y; Mohri S; Kitamoto T
    Acta Neuropathol Commun; 2014 Mar; 2():32. PubMed ID: 24685293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease.
    Meissner B; Kallenberg K; Sanchez-Juan P; Collie D; Summers DM; Almonti S; Collins SJ; Smith P; Cras P; Jansen GH; Brandel JP; Coulthart MB; Roberts H; Van Everbroeck B; Galanaud D; Mellina V; Will RG; Zerr I
    Neurology; 2009 Jun; 72(23):1994-2001. PubMed ID: 19506221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique clinicopathological features and PrP profiles in the first autopsied case of dura mater graft-associated Creutzfeldt-Jakob disease with codon 219 lysine allele observed in Japanese population.
    Ikawa M; Yoneda M; Matsunaga A; Nakagawa H; Kazama-Suzuki A; Miyashita N; Naiki H; Kitamoto T; Kuriyama M
    J Neurol Sci; 2009 Oct; 285(1-2):265-7. PubMed ID: 19666177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the phenotypic spectrum of sporadic Creutzfeldt-Jakob disease MV2K: the kuru plaque type.
    Baiardi S; Mammana A; Dellavalle S; Rossi M; Redaelli V; Colaizzo E; Di Fede G; Ladogana A; Capellari S; Parchi P
    Brain; 2023 Aug; 146(8):3289-3300. PubMed ID: 36883639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Combination of Prion Strain Co-Occurrence in Patients with Sporadic Creutzfeldt-Jakob Disease.
    Kobayashi A; Iwasaki Y; Takao M; Saito Y; Iwaki T; Qi Z; Torimoto R; Shimazaki T; Munesue Y; Isoda N; Sawa H; Aoshima K; Kimura T; Kondo H; Mohri S; Kitamoto T
    Am J Pathol; 2019 Jun; 189(6):1276-1283. PubMed ID: 30926338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.